Group A streptococci produce three antigenically distinct pyrogenic exotoxins (also called SPEs, scarlet fever toxins. and erythrogenic toxins), designated types A, B, and C (17) . These toxins cause scarlet fever and have been implicated in a toxic shock-like syndrome (TSLS) (6, 17). The biological properties of the toxins include pyrogenicity, enhancement of lethal shock and myocardial damage due to endotoxin or streptolysin 0, and induction of nonspecific T lymphocyte mitogenicity (2, 9, 13, 15; for a review, see reference 17) . This last effect probably contributes to the development of the scarlet fever rash in a susceptible host (13) . Many of these properties are shared with staphylococcal toxins associated with toxic shock syndrome (TSS), and SPEs share significant sequence homology with TSS-associated toxins (3, 5, 7).
In 1979, Schlievert et al. (12) determined that toxin types B and C were more commonly made by group Hyperimmune rabbit antibodies against SPEs A, B, and C were prepared (11); these sera did not cross-react with heterologous toxins when tested by Ouchterlony immunodiffusion. SPEs for immunization were made after culture of streptococci in a dialyzable beef heart medium, followed by ethanol precipitation. resolubilization in acetate-buffered saline, and preparative thin-layer isoelectric focusing (11) . SPE A, B, and C concentrations were estimated by serial-dilution Ouchterlony immunodiffusion (14) . The lower limit of detectable purified toxin was 6 ptg/ml for ail SPE types. Strains to be tested for toxin production were grown to stationary phase in beef heart medium (SPEs are maximally produced during late log phase, and no additional toxin is expressed during stationary phase) and then were toxin concentrated 100-fold by ethanol precipitation and resolubilization in water (lower limit of toxin detection, 0.06 Ftg/ml of original culture fluid The pumps, which are designed to exchange a constant amount of volume over 7 days, were inserted into small (1-cm) incision sites on the flanks of the rabbits as described previously in studies of TSS toxin 1 (10), in which that toxin induced TSS-like signs. After their surgical wounds were sutured, the rabbits were monitored daily for up to 9 days in the following categories: weight loss, rectal temperature change, stool and urine change, redness of conjunctivae and ears, and death. Baseline weight and rectal temperature for each rabbit were taken 1 day prior to pump implantation. The range of weight change from baseline and the maximal temperature rise above baseline during the experimental period were recorded.
Student's t test analysis of unpaired, normally distributed data was used to determine differences between means of groups.
Twenty-six streptococcal strains from apparent TSLS in 1987 and 1988 were tested for SPE production (Table 1) . Of these, 23 were SPE A producers, with an average concentration of 3.2 jig of toxin per mi of culture as determined by quantitative Ouchterlony immunodiffusion (range, 0.1 to 7.7 p.g/ml of culture). Ten isolates were SPE B producers. making an average of 0.7 .tg/ml of culture (range. 0.06 to 1.9 F.g/ml), and only eight expressed SPE C at an average of 0.6 F.g/ml (range, 0.06 to 1.9 fig/ml). Thus, SPE A was made in significantly greater amounts than B or C (P < 0.002 and P < 0.004, respectively). Of the 26 strains, 13 made SPE A only. 3 made C only, 5 made A and B together, and 5 made all three SPEs. There was no significant correlation between expression of one or more than one toxin and the amount of toxin produced. Also, statistically significant differences between SPE B and SPE C concentrations were not seen.
In addition to greater production of SPE A versus B or C by TSLS-associated streptococcal strains, it was also possible that SPE A was intrinsically more toxic to animals than SPE B or C. Implantation of miniosmotic pumps containing either SPE A or SPE C showed the effects of toxin type and various toxin concentrations on rabbits (Table 2) ; SPE B was not tested because in previous studies this toxin was 10-fold less active than either A or C (1). None of the control. non-toxin-treated rabbits (group 1) died or showed signs of illness; instead, they gained an average of 52 g and showed only an average of 0.4°C maximal temperature rise above baseline during the experimental period. Groups 2 (SPE A) and 5 (SPE C), both given 15 p.g/mI, also did not lose any rabbits and had only small average temperature increases over baseline (0.6°C for group 2 and 1.0°C for group 5).
However, al of the rabbits in both groups showed similar signs of weight loss (average of 60 g for group 2 and 35 g for group 5); diarrhea; clear, dark-yellow urine; and reddening of eyes and ears.
Implants with higher toxin concentrations (150 and 300 F.g of toxin) induced increased responses in rabbits from groups Included Nveight luss. diarrhea. urine clearing and change tu dark yellow (normal urine is chalkv. velluw-white). fever. and reddening of eyes and cars.
3 and 4 (SPE A) and groups 6 and 7 (SPE C). All of the rabbits in SPE A groups 3 (150 Fxg of toxin) and 4 (300 p.g) exhibited signs of illness as described above along with the most severe weight loss and fever response, and seven of eight animals succumbed. The average maximal temperature rises above baseline were 1.5°C for group 3 and 2.0°C for group 4. Both groups lost over 100 g of weight during the experimental period.
In contrast to SPE A (groups 3 and 4), SPE C was not highly lethal (groups 6 and 7) to rabbits. All rabbits in SPE C groups 6 and 7 exhibited signs of illness and lost nearly 100 g of weight during the experimental periods, but only one of four in group 6 and none from group 7 died. Also, the average maximal temperature rise above baseline during the entire experimental period was only 1.2°C for both groups, compared with 1.5 and 2.0 for SPE A-challenged animals.
We conclude that SPE A production is highly associated with TSLS and that the severe illness produced by these strains may be the result of both greater toxin production by SPE 
